Here's what we'll cover
Here's what we'll cover
The pharmacist says $1,349 for a month of Wegovy. You expected maybe $100, $200. But $1,349? That is $16,188 a year, more than many people pay for rent.
Then your friend says they pay $149. Same medication, same dose. Your coworker pays $50 through Medicare. Another colleague gets it for $247 from a compounding pharmacy.
How can the same medication cost $149, $247, $1,349, or $50 depending on where you get it? The answer involves insurance formulary tiers, manufacturer savings programs, compounded alternatives, Medicare demonstration programs, and a pharmaceutical pricing system designed to be intentionally opaque.
This guide breaks down exactly what you will pay for GLP-1 medications in 2026 based on your insurance type, available programs, and access to alternatives. We will show you the list prices, the real prices people actually pay, hidden costs you need to budget for, and how to find the lowest price for your specific situation.
List Prices (What Almost Nobody Pays)
GLP-1 List Prices 2026 (Without Insurance or Discounts)
Important Context: These are Wholesale Acquisition Cost (WAC) prices, also called list prices. They represent what pharmacies pay before rebates and discounts. Almost nobody pays these prices because:
- Insurance negotiates lower rates
- Manufacturers offer savings programs
- Pharmacy benefit managers receive rebates
- Cash-pay programs provide discounts
Who Actually Pays List Price:
- Uninsured patients without access to savings programs
- Patients with high-deductible plans before deductible met
- International customers in countries without pricing regulations
- Patients whose insurance explicitly excludes weight-loss medications and who don't know about alternatives
Why List Prices Matter: Even though few pay full price, list price determines:
- Your coinsurance percentage (20% of $1,349 = $270 monthly)
- How fast you hit your deductible
- Manufacturer savings program maximum assistance
- Whether medication is placed on specialty tier
Medicare Pricing 2026
GENEROUS Model: $50 Copay
Eligibility (Phase 1, April-December 2026):
- BMI 27+ with cardiovascular disease, OR
- BMI 27+ with prediabetes (A1C 5.7-6.4%), OR
- BMI 30+ with hypertension
Pricing:
- Beneficiary pays: $50/month
- Medicare pays: $245/month
- Total program cost: $295/month
12-Month Cost: $600
Phase 2 Expansion (January 2027):
- BMI 30+ without additional comorbidities
- BMI 27+ with chronic kidney disease or heart failure
- Copay: Expected to remain $50
What This Doesn't Cover:
- Beneficiaries who don't meet Phase 1 or 2 criteria
- Weight loss without qualifying comorbidities
- Compounded medications (not FDA-approved)
Traditional Medicare Part D (Diabetes Coverage)
Covers:
- Ozempic, Mounjaro, Trulicity for type 2 diabetes
- NOT Wegovy or Zepbound (weight loss indication)
Typical Costs:
- Deductible phase: $545 deductible in 2026
- Initial coverage: 25% coinsurance = $242-$337/month
- Coverage gap: 25% until catastrophic threshold
- Catastrophic phase: $4-$5 copay
12-Month Cost (Diabetes Indication): $2,400-$3,800
Medicaid Pricing
13 States With Coverage: Arizona, Arkansas, Colorado, Connecticut, Illinois, Louisiana, Massachusetts, New Mexico, New York, Oregon, Rhode Island, Vermont, Washington
Typical Copays: $0-$10/month
12-Month Cost (In Coverage States): $0-$120
37 States Without Coverage:
- Full list price unless using manufacturer programs
- Alternative: Compounded medications
- Some patients move or travel to coverage states temporarily
Recent Eliminations (January 2026): California, Pennsylvania, Michigan all eliminated weight-loss coverage, affecting 20.2 million Medicaid beneficiaries.
Commercial Insurance Costs
With Prior Authorization Approval
Formulary Tier Determines Your Copay:
Tier 2 (Preferred Brand):
- Typical copay: $25-$75 (varies significantly by plan; some plans charge $100-$200+ or use coinsurance instead of flat copays)
- Rare for GLP-1s (only if employer negotiated preferred status)
- 12-month cost: $300-$900
Tier 3 (Non-Preferred Brand):
- Typical copay: $75-$150 (varies by plan)
- Most common placement for covered GLP-1s
- 12-month cost: $900-$1,800
Tier 4 (Specialty):
- Coinsurance: 20-33% of list price
- 20% of $1,349 = $270/month
- 12-month cost: $3,240-$5,328
Note: Copay and coinsurance amounts vary widely by plan type, employer, and region. Figures above represent common ranges but may not reflect your specific plan. Many plans are shifting from flat copays to percentage-based coinsurance in 2026. Check your plan's Summary of Benefits for exact cost-sharing. Sources: KFF 2025 Employer Health Benefits Survey; SavingAdvice.com, Jan 2026
High-Deductible Plans: Before deductible met, you pay full price:
- Months 1-3: $1,349/month × 3 = $4,047
- After deductible: Tier copay applies
- 12-month cost: $5,000-$8,000 (deductible $3,000-$6,000 + copays)
Without Coverage (Plan Excludes Weight Loss)
Options:
- Pay list price: $1,349/month = $16,188/year
- Use manufacturer savings program: $199-$349/month
- Switch to compounded alternative: $197-$397/month
- Appeal denial (30-40% success rate)
Manufacturer Savings Programs (Best Value for Most People)
Novo Nordisk Programs
Injectable Wegovy:
- Months 1-2: $199/month (limited time through GoodRx, 11/17/25-3/31/26)
- Months 3+: $349/month
- 12-month cost: $4,188 ($199×2 + $349×10)
Oral Wegovy Pill:
- 1.5mg and 4mg doses: $149/month (through 4/15/26), then $199/month for 4mg only
- 9mg and 25mg doses: $299/month
- 12-month cost: $2,388-$3,588 depending on dose
Eligibility:
- No commercial insurance coverage for weight loss, OR
- Commercial insurance patients can use instead of insurance
- Cannot combine with insurance benefits
- Cannot be Medicare or Medicaid beneficiary
How to Enroll:
- Get prescription from doctor
- Visit WegovyDirect.com or use GoodRx
- Prescription sent to Novo Nordisk specialty pharmacy or GoodRx network
- Medication ships refrigerated to home
- Auto-refill available
Eli Lilly Programs
Zepbound Vials (Self-Injection):
- Pricing: $399-$549/month depending on dose
- Requires: Drawing medication from vial into syringe, self-injecting
- 12-month cost: $4,788-$6,588
Why Vials Cost Less:
- 60-70% cheaper to manufacture than pens
- No auto-injector device costs
- Lilly positioned vials as affordable option
Zepbound Pens:
- Not available through direct program
- Must use insurance or pay full list price $1,059
Eligibility:
- Uninsured patients
- Commercial insurance patients with coverage denials
- Cannot combine with any insurance benefit
How to Enroll:
- Visit LillyDirect.com
- Upload prescription or connect doctor
- Choose vial dosing (2.5mg through 15mg)
- Pay online, medication ships within 7 days
Cost Comparison: Novo vs Lilly Programs
Year 1 Costs:
- Oral Wegovy pill (low dose): $1,788-$2,388
- Injectable Wegovy: $4,188
- Zepbound vials: $4,788-$6,588
Most Affordable: Oral Wegovy pill at launch pricing
Compounded Semaglutide and Tirzepatide Pricing
What Compounding Means
Now that FDA-recognized shortages of semaglutide and tirzepatide have been resolved, compounding pharmacies can no longer produce exact copies of FDA-approved GLP-1 products for routine dispensing. However, 503A compounding pharmacies may still legally produce GLP-1 formulations that are not "essentially a copy" of commercial products - such as different doses or concentrations, alternative formulations (e.g., sublingual or oral), or GLP-1 combined with additional ingredients (e.g., B12, L-carnitine). These require a valid patient-specific prescription with documented medical necessity. The active ingredient is the same, but the finished product is not FDA-approved.
Pricing by Platform
Telehealth Platforms:
- Hims/Hers: $197-$347/month (semaglutide or tirzepatide)
- Ro: $245-$395/month
- Henry Meds: $247-$347/month
- Manual: $249-$349/month
What's Included:
- Virtual doctor consultation
- Medication shipped to home
- Monthly check-ins via app
- Injection supplies (syringes, alcohol wipes, sharps container)
12-Month Costs: $2,364-$4,740
Quality Considerations
503B vs 503A:
- 503B facilities: FDA-registered outsourcing facilities, higher oversight, batch testing required
- 503A pharmacies: Traditional compounding, less oversight, testing varies
How to Verify Quality:
- Ask if pharmacy is 503B registered
- Request certificate of analysis (COA) for your batch
- Verify USP 797 compliance (sterile compounding standards)
- Check for FDA warning letters (search pharmacy name + "FDA")
Risk: The regulatory landscape around compounded GLP-1s is evolving rapidly. The FDA is actively enforcing against compounders producing "essentially copies" of commercially available products, and both Novo Nordisk and Eli Lilly are pursuing legal action against compounders and telehealth platforms.
Hidden Costs to Budget For
Supplies (If Using Injectable)
Sharps Container: $15-$25 (lasts 3-6 months)
- Required for safe needle disposal
- Available at pharmacies, Amazon
Alcohol Wipes: $5-$10/month (if not included)
- Some programs include, others don't
Extra Syringes (Vials Only): $10-$20/month
- Needed if using Zepbound vials or compounded
Total Supply Costs: $20-$50/month = $240-$600/year
Medical Monitoring
Doctor Visits:
- Telehealth: $0-$49/month (included with some programs)
- In-person PCP: $0-$200/visit (quarterly minimum)
- Specialist: $150-$300/visit (initial consultation)
Lab Work:
- Baseline labs: $100-$200 (A1C, CMP, lipids, TSH)
- Monitoring labs: $50-$150 every 3 months
- Total annual: $200-$800
Shipping Fees
Refrigerated Shipping:
- Most programs: Included
- Some charge: $10-$15/shipment
- Annual if charged: $120-$180
Total Cost Scenarios Over 12 Months
12-Month Total Cost Scenarios by Insurance Type
Key Insights:
- 27-fold difference between best and worst case ($600 vs $16,788)
- Manufacturer programs cost 70-75% less than list price
- Oral Wegovy pill currently cheapest brand-name option
- Hidden costs add $200-$800 annually
How to Find the Lowest Price for Your Situation
Decision Tree
Step 1: Check Medicare Eligibility
- Age 65+ OR on disability Medicare?
- BMI 27+ with CVD, prediabetes, or hypertension? → YES: Apply for GENEROUS model ($50/month) → NO: Go to Step 2
Step 2: Check Medicaid Eligibility
- Live in one of 13 coverage states?
- Meet state-specific BMI + criteria? → YES: Work with doctor on prior authorization ($0-$10/month) → NO: Go to Step 3
Step 3: Check Commercial Insurance
- Does your plan cover GLP-1s for weight loss? → YES: Submit prior authorization ($50-$337/month depending on tier) → NO: Go to Step 4
Step 4: Compare Cash-Pay Options
Prefer Oral:
- Oral Wegovy pill: $149-$299/month (best brand option)
Prefer Injectable, Want Brand-Name:
- Injectable Wegovy: $199-$349/month
- Zepbound vials: $399-$549/month (if comfortable with vials)
Cost-Conscious, OK with Compounded:
- Telehealth platforms: $197-$397/month
- Verify 503B registration and quality standards
Prescription Discount Cards
GoodRx:
- Wegovy injectable: $199 months 1-2, $349 after (through 3/31/26)
- Wegovy pill: $149 for low doses (through 4/15/26)
- Works at 70,000+ pharmacies nationwide
SingleCare, RxSaver:
- Competitive pricing on some GLP-1s
- Compare with GoodRx before filling
Important:
- Discount cards cannot be combined with insurance
- Choose: use insurance OR use discount card, not both
- Some plans prohibit discount card use (rare)
Patient Assistance Programs
NeedyMeds, RxAssist:
- Search for manufacturer assistance programs
- Income-based eligibility (typically <400% federal poverty level)
- Free or deeply discounted medication
Eligibility Example:
- Household income <$60,240 (single person) or <$124,800 (family of 4)
- No insurance coverage or inadequate coverage
- US citizen or legal resident
The Bottom Line
GLP-1 medication costs in 2026 range from $600 to $16,788 annually depending on insurance type, access to manufacturer programs, and willingness to use compounded alternatives.
Lowest Cost Options:
- Medicare GENEROUS model: $50/month ($600/year) if eligible
- Medicaid in coverage states: $0-$10/month ($0-$120/year)
- Oral Wegovy launch pricing: $149/month ($1,788/year)
- Commercial insurance Tier 3: $125/month ($1,500/year)
Mid-Range Options:
- Compounded semaglutide: $197-$397/month ($2,364-$4,764/year)
- Injectable Wegovy manufacturer program: $308 avg/month ($4,188/year)
- Zepbound vials: $474 avg/month ($6,168/year)
Highest Cost:
- High-deductible plans before deductible met: $7,000-$9,000/year
- No insurance, no programs: $16,188/year
Hidden costs add $200-$800 annually: Supplies, medical monitoring, potential shipping fees.
Key strategies to minimize costs:
- Prefer oral formulations when available (currently cheapest at $149-$299)
- Use manufacturer programs if insurance doesn't cover (70-75% savings vs list price)
- With HDHPs, manufacturer programs often cheaper than using insurance
- Apply for Medicare GENEROUS if eligible (starting April 2026)
- Check state Medicaid coverage if income-eligible
- Consider compounded alternatives with proper quality vetting
2027 outlook: Prices expected to decrease 40-60% for Medicare beneficiaries once IRA drug price negotiation takes effect. Commercial insurance pricing may follow.
The pharmaceutical pricing system is intentionally complex, but understanding your options can save you $10,000+ annually compared to paying list price.
Disclaimer: Please note that compounded medications are not reviewed by the FDA for safety, quality, or efficacy. Any medication changes should be made under the guidance of a licensed healthcare provider.
No waiting list. No insurance needed.
Fequently Asked Questions
Can I use manufacturer coupons with insurance?
Medicare and Medicaid beneficiaries cannot use manufacturer coupons due to federal anti-kickback laws. Commercial insurance patients can usually use coupons, but some plans have "coupon accumulator" programs that prevent copay assistance from counting toward your deductible. Fourteen states (Arizona, Arkansas, Connecticut, Delaware, Georgia, Illinois, Kentucky, Louisiana, North Carolina, Oklahoma, Tennessee, Virginia, West Virginia, Puerto Rico) have banned coupon accumulators.
Is compounded semaglutide safe?
Compounded medications can be safe if produced by reputable pharmacies, but quality varies since FDA doesn't approve compounded finished products. Only use 503B registered pharmacies with higher FDA oversight, request a certificate of analysis for your batch, and verify USP 797 compliance for sterile compounding. Note: FDA-recognized GLP-1 shortages were resolved in early 2025. Compounding of exact copies is no longer permitted, though 503A pharmacies may still produce non-copy formulations (different doses, combinations with additional ingredients) with documented medical necessity.
Can I switch between oral and injectable GLP-1s?
Yes, switching between oral and injectable semaglutide is straightforward with no washout period needed (oral 25mg daily ≈ injectable 2.4mg weekly). Switching between different medications (semaglutide to tirzepatide) requires 4-5 week washout and re-titration over 16-20 weeks. Insurance may require new prior authorization for different formulations, and oral Wegovy currently costs less ($149-$299) than injectable ($199-$349).
How much does it cost if I have a high-deductible health plan?
HDHPs typically cost $7,000-$9,000 annually because you pay full price ($1,349/month) until meeting your $3,000-$7,000 deductible, then 20% coinsurance after. Manufacturer programs ($199-$349/month) or compounded options ($197-$397/month) usually cost less than using insurance with HDHP. Use HSA funds if available for 22-37% tax savings, or time your start after other medical expenses meet your deductible.
Will prices go down in 2027?
Yes, Medicare's Inflation Reduction Act drug price negotiation begins January 2027, expected to reduce prices 40-60% (from $1,349 to estimated $540-$810/month). Orforglipron (new Eli Lilly oral GLP-1) approval expected Q2 2026 may increase competition and lower prices. First generic semaglutide won't arrive until patents expire in 2032-2033, when prices typically drop 70-90%.
What happens to pricing if I lose my job and insurance?
You immediately become eligible for manufacturer programs ($199-$349/month Novo Nordisk, $399-$549/month Eli Lilly), which are usually cheaper than COBRA. You have 60-day special enrollment period for marketplace insurance (may require new prior authorization). Enroll in manufacturer program immediately to avoid medication gap, then evaluate COBRA ($600-$800/month premium + copay) vs marketplace vs Medicaid options within 30 days.